{
    "id": "a70488d7-57ea-446e-89c2-87b0ecc90023",
    "indications": {
        "text": "nuvigil indicated improve wakefulness adult patients excessive sleepiness associated obstructive sleep apnea ( osa ) , narcolepsy , shift work disorder ( swd ) . limitations osa , nuvigil indicated treat excessive sleepiness treatment underlying obstruction . continuous positive airway pressure ( cpap ) treatment choice patient , maximal effort treat cpap adequate period time made prior initiating nuvigil excessive sleepiness .",
        "doid_entities": [
            {
                "text": "obstructive sleep apnea (DOID:0050848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050848"
            },
            {
                "text": "sleep apnea (DOID:0050847)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050847"
            },
            {
                "text": "narcolepsy (DOID:8986)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8986"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended nuvigil indication follows : osa narcolepsy : 150 mg 250 mg day morning . ( 2.1 ) swd : 150 mg day , taken approximately one hour prior start work shift . ( 2.2 ) hepatic impairment : reduced dose patients severe hepatic impairment . ( 2.3 , 12.3 ) geriatric patients : consider lower dose . ( 2.4 , 12.3 )",
        "doid_entities": [
            {
                "text": "narcolepsy (DOID:8986)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8986"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "nuvigil\u00ae ( armodafinil ) tablets available follows : 50 mg : round , white off-white tablet debossed one side `` 205 `` other.ndc 63459-205-30 \u2013 bottles 30 150 mg : oval , white off-white tablet debossed one side `` 215 `` other.ndc 63459-215-30 \u2013 bottles 30 200 mg : rounded , rectangular , white off-white tablet debossed one side `` 220 `` other.ndc 63459-220-30 \u2013 bottles 30 250 mg : oval , white off-white tablet debossed one side `` 225 `` other.ndc 63459-225-30 \u2013 bottles 30",
    "adverseReactions": "nuvigil contraindicated patients known hypersensitivity modafinil armodafinil inactive ingredients [ ( 5.1 , 5.2 , 5.3 ) ] .",
    "ingredients": [
        {
            "name": "ARMODAFINIL",
            "code": "V63XWA605I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77590"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        }
    ],
    "organization": "Cephalon, LLC",
    "name": "Nuvigil",
    "effectiveTime": "20221231",
    "indications_original": "NUVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).\n                  \n                     Limitations of Use\n                  \n                  In OSA, NUVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.  If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating NUVIGIL for excessive sleepiness.",
    "contraindications_original": "The recommended dosage of NUVIGIL for each indication is as follows: OSA or Narcolepsy: 150 mg to 250 mg once a day in the morning. ( 2.1 ) SWD: 150 mg once a day, taken approximately one hour prior to start of the work shift. ( 2.2 ) Hepatic Impairment: reduced dose in patients with severe hepatic impairment. ( 2.3 , 12.3 ) Geriatric Patients: consider lower dose. ( 2.4 , 12.3 )",
    "warningsAndPrecautions_original": "NUVIGIL\u00ae (armodafinil) Tablets are available as follows:\n                        50 mg:  Each round, white to off-white tablet is debossed with \u00a0 on one side and \"205\" on the other.NDC 63459-205-30 \u2013 Bottles of 30\n                        150 mg: Each oval, white to off-white tablet is debossed with \u00a0 on one side and \"215\" on the other.NDC 63459-215-30 \u2013 Bottles of 30\n                        200 mg: Each rounded, rectangular, white to off-white tablet is debossed with \u00a0 on one side and \"220\" on the          other.NDC 63459-220-30 \u2013 Bottles of 30\n                        250 mg: Each oval, white to off-white tablet is debossed with \u00a0 on one side and \"225\" on the other.NDC 63459-225-30 \u2013 Bottles of 30",
    "adverseReactions_original": "NUVIGIL is contraindicated in patients with known hypersensitivity to modafinil or armodafinil or its inactive ingredients [see Warnings and Precautions (5.1, 5.2, 5.3)].",
    "drug": [
        {
            "name": "Nuvigil",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77590"
        }
    ]
}